Dazodalibep

3 trials 2 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

12 Countries

Phase III

Phase III: 3

Indications tested

Sjogren's syndrome 2 Sjogren´s syndrome 1

Sponsors using this IMP

Horizon Therapeutics Ireland Designated Activity Company 2 Amgen Inc. 1

All trials

3 total

A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2023-503904-10-00 Phase III 12 countries Horizon Therapeutics Ireland Designated Activity Company
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2024-517513-32-00 Phase III 12 countries Amgen Inc.
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome Ended

2023-503923-24-00 Phase III 12 countries Horizon Therapeutics Ireland Designated Activity Company

Showing 1–3 of 3 trials

← All drugs A–Z